Smith Andrew Alasdair bought MDCX
September 4, 2026 · Form 4 insider transaction
Smith Andrew Alasdair bought 735,294 shares of Medicus Pharma Ltd. at $0.17 per share, a transaction worth $125.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
735,294
Price
$0.17
Total value
$125.4K
InsiderSmith Andrew Alasdair
Role—
CompanyMedicus Pharma Ltd. (MDCX)
SecurityCommon Shares, no par value
Transaction codeA: Grant or award
Transaction dateSeptember 4, 2026
Filing dateSeptember 8, 2026
Shares owned after735,458
OwnershipDirect
10b5-1 planNo
AmendedNo